4.3 Review

Recent Advances in the Study on Resveratrol

期刊

BIOLOGICAL & PHARMACEUTICAL BULLETIN
卷 35, 期 3, 页码 273-279

出版社

PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.35.273

关键词

resveratrol; cyclooxygenase; peroxisome proliferator-activated receptor; endothelial nitric oxide synthase; silent mating type information regulation 2 homolog 1

资金

  1. Ministry of Education, Culture, Sports, Science and Technology of Japan [19300250]
  2. Iijima Memorial Foundation for the Promotion of Food Science and Technology
  3. Grants-in-Aid for Scientific Research [19300250, 22650173] Funding Source: KAKEN

向作者/读者索取更多资源

Appropriate long-term drinking of red wine is associated with a reduced risk for lifestyle-related diseases such as cardiovascular disease and cancer, making resveratrol, a constituent of grapes and various other plants, an attractive compound to be studied. Historically, resveratrol has been identified as a phytoalexin, antioxidant, cyclooxygenase (COX) inhibitor, peroxisome proliferator-activated receptor (PPAR) activator, endothelial nitric oxide synthase (eNOS) inducer, silent mating type information regulation 2 homolog I (SIRT1) activator, and more. Despite scepticism concerning the biological availability of resveratrol, a growing body of in viva evidence indicates that resveratrol has protective effects in several stress and disease models. Here, we provide a review of the studies on resveratrol, especially with respect to COX, PPAR, and eNOS activities, and discuss its potential for promoting human health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据